DOCSLIB.ORG

Lab Code Test Name

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lab Code Test Name LAB CODE TEST NAME MSHS 70408 11-DESOXYCORTISOL MSHS 73937 11-DESOXYCORTISOL MSHS 1762 17-HYDROXYCORTICOSTER. Container:Urine Container Temperature:Frozen MSHS 72315 17-HYDROXYCORTICOSTEROIDS MSHS 4713 17-KETOSTEROIDS 24HR UR.W/CREAT Container:Urine Container Temperature:Refrigerate MSHS 70204 17-OH PROGESTERONE LCMS MSHS 4077 17-OH-CORTICOSTEROID W/CR Container:Urine Container Temperature:Refrigerate MSHS 50752 2,3-DINOR-11 BETA-PROSTAGLANDIN F2 ALPHA, UR Container:Lavender Top Tube Temperature:Refrigerate MSHS 70412 21-HYDROXYLASE ABS MSHS 73949 25-Hydroxyvitamin D LCMS D2+D3 MSHS 9022 3RD. TRIMESTER PANEL Temperature:Refrigerate MSHS 50488 4-HYDROXYBUTYRIC ACID, CSF Container:Sterile Container Temperature:Frozen MSHS 70087 5' NUCLEOTIDASE MSHS 6090 5-FLUCYTOSINE ASSAY Container:Yellow Top Tube Temperature:Refrigerate MSHS 72591 5-HIAA, PLASMA MSHS 70345 5-HIAA,QUANT,24 HR URINE MSHS 50480 5-METHYLTETRAHYDROFOLATE, CSF Container:Sterile Container Temperature:Frozen MSHS 3360 6-TEST - ARTERIAL Container:ASY MSHS 3660 6-TEST - VENOUS Container:VSY MSHS 7344 A SUBGROUPING Container:Pink Top Tube Temperature:Refrigerate MSHS 6320 A. PULLULANS IGE Container:Gold SST Ref Lab Temperature:Refrigerate MSHS 70413 A1A ELISA, RANDOM STOOL MSHS 50066 ABL MUTATION,LEUMETA KINASE Container:Lavender Top Tube Temperature:Refrigerate MSHS 4767 ABL T315I MUTATION Container:Lavender Top Tube Temperature:Refrigerate MSHS 7004 ABNORMAL APTT EVAL Container:Blue Top Tube Temperature:Refrigerate MSHS 6618 ABNORMAL PT EVALUATION Temperature:Refrigerate Page 1 of 308 LAB CODE TEST NAME Temperature:Refrigerate MSHS 6416 ABO AND RH Container:Pink Top Tube Temperature:Refrigerate MSHS 10065 ABORH CONFIRM Container:Pink Top Tube Temperature:Refrigerate MSHS 72596 ACE, CSF MSHS 1149 ACETAMINOPHEN Container:Gold Top Tube Temperature:Refrigerate MSHS 72543 ACETAZOLAMIDE, SERUM MSHS 70215 ACETONE MSHS 60575 ACH RECEPTOR (MUSCLE) BINDING AB Container:Red Top Temperature:Refrigerate MSHS 72926 ACH RECEPTOR (MUSCLE) MODULATING AB Container:Red Top Temperature:Refrigerate MSHS 70030 ACHR BINDING ABS, SERUM MSHS 70031 ACHR BLOCKING ABS, SERUM MSHS 70006 ACHR MODULATING AB MSHS 73994 AChR MODULATION FLOW CYTOMETRY, MSHS 4797 ACID ALPHA-GLUCOSIDASE, BLOOD SPOT Container:SPECIAL CONTAINER Temperature:Refrigerate MSHS 50373 ACID FAST STAIN, PARTIAL OR MODIFIED Container:Glass Slide Temperature:Refrigerate MSHS 70414 ACID LABILE SUBUNIT MSHS 70150 ACTH, PLASMA Container:Lavender Top Tube Temperature:Frozen MSHS 72592 ACTH, PLASMA MSHS 70089 ACTIN (SMOOTH MUSCLE) AB MSHS 72588 ACTIN IGA (F-ACTIN) MSHS 6403 ACUTE HEPATITIS PANEL Container:SS2 GOLD2 GOLD aliquot 2 Temperature:Refrigerate MSHS 72572 ACYCLOVIR, SERUM/PLASMA MSHS 50011 ADAMTS13 ACTIVITY & INHIBITOR Container:Lt Blue NaCit Ref Lab Temperature:Frozen MSHS 6966 ADENOSINE DEAM., CSF Container:Sterile Container Temperature:Frozen MSHS 6965 ADENOSINE DEAM.,PLEURAL Container:Sterile Container Temperature:Refrigerate MSHS 50754 ADENOSINE DEAMINASE, PERICARDIAL FLUID Container:Yellow Top Tube Temperature:Refrigerate Page 2 of 308 LAB CODE TEST NAME MSHS 70415 ADENOSINE DEAMINASE,PERITONEAL MSHS 70416 ADENOSINE DEAMINASE,PLEURAL FL MSHS 4335 ADENOVIRUS AG DFA Container:Sterile Container Temperature:Refrigerate MSHS 70094 ADENOVIRUS GROUP AB, QN MSHS 50595 ADENOVIRUS PCR, STOOL Container:Special Coll Ref Lab Temperature:Frozen MSHS 6854 ADENOVIRUS QNT. PCR, UR Container:Urine Container Temperature:Refrigerate MSHS 6853 ADENOVIRUS QUANT PCR Container:Lavender Top Tube Temperature:Frozen MSHS 70218 ADH MSHS 6241 ADIPONECTIN Container:Gold SST Ref Lab Temperature:Refrigerate MSHS 74007 ADIPONECTIN MSHS 72073 ADRENOCORTICOTROPIC HORM MSHS 5579 ADULT FOOD PROFILE Temperature:Refrigerate MSHS 4880 AFB (FLUOROCHROME) SMEAR Container:Sterile Container Temperature:Refrigerate MSHS 4322 AFB CUL.MISCELLANEOUS Container:Sterile Container Temperature:Refrigerate MSHS 4317 AFB CULTURE, BLOOD Container:Yellow Top Tube Temperature:Refrigerate MSHS 4318 AFB CULTURE, CSF Container:Sterile Container Temperature:Refrigerate MSHS 480 AFB CULTURE, RESPIRATORY Container:Sterile Container Temperature:Refrigerate MSHS 4346 AFB CULTURE, TISSUE Container:Sterile Container Temperature:Refrigerate MSHS 70628 AFB IDENTIFICATION MSHS 488 AFB SMEAR ONLY Container:Sterile Container Temperature:Refrigerate MSHS 70417 AFP WITH AFP-L3% MSHS 70629 AFP, SERUM, OPEN SPINA BIFIDA MSHS 2120 AGAR GEL ELECTRO. Container:Lavender Top Tube Temperature:Refrigerate MSHS 73235 AGNA-1 IMMUNOBLOT, S Container:Red Top Temperature:Refrigerate MSHS 1105 ALBUMIN Container:Gold Top Tube Page 3 of 308 Temperature:Refrigerate LAB CODE TEST NAME Container:Gold Top Tube Temperature:Refrigerate MSHS 8613 ALBUMIN CSF Container:Screw Cap Tube Temperature:Refrigerate MSHS 3256 ALBUMIN FLUID Container:Sterile Container Temperature:Refrigerate MSHS 3036 ALBUMIN, PERITONEAL Container:Yellow Top Tube Temperature:Refrigerate MSHS 1178 ALCOHOL (QUANT) SERUM Container:Yellow Top Tube or SST tube Temperature:Refrigerate MSHS 70000 ALDOLASE MSHS 70211 ALDOSTERONE Container:Gold SST Ref Lab Temperature:Refrigerate MSHS 60885 ALDOSTERONE MSHS 70346 ALDOSTERONE, URINE MSHS 70420 ALK PHOS ISOENZYME MSHS 70419 ALK PHOSPHATASE, BONE SPECIFIC MSHS 1134 ALK.PHOSPHATASE Container:Gold Top Tube Temperature:Refrigerate MSHS 5232 ALMOND - F20 Container:Gold Top Tube Temperature:Refrigerate MSHS 50448 ALPHA 1 ACID GLYCOPROTEIN(AAG) Container:Gold SST Ref Lab Temperature:Refrigerate MSHS 1719 ALPHA FETOPROTEIN Container:Gold Top Tube Temperature:Refrigerate MSHS 73236 ALPHA INTERNEXIN CBA, S Container:Red Top Temperature:Refrigerate MSHS 70423 ALPHA SUBUNIT (FREE) MSHS 70199 ALPHA-1-ANTITRYPSIN MSHS 70422 ALPHA-1-ANTITRYPSIN DEFICIENCY MSHS 70421 ALPHA-1-ANTITRYPSIN PHENOTYPE MSHS 70152 ALPHA-2-ANTIPLASMIN MSHS 50487 ALPHA-AMINOADIPIC SEMIALDEHYDE, CSF Container:Sterile Container Temperature:Frozen MSHS 72544 ALPHA-GALACTOSIDASE A MSHS 4756 ALPHA-GLOBIN COMMONMUT Container:Lavender Top Tube Temperature:Refrigerate MSHS 72093 ALPHA-THALASSEMIA MSHS 1143 ALT(SGPT) Container:Gold Top Tube Temperature:Refrigerate Page 4 of 308 LAB CODE TEST NAME MSHS 7414 ALT/AST Container:SS1 GOLD1 GOLD aliquot 1 Temperature:Refrigerate MSHS 5421 ALTERNARIA TENUIS -M6 Container:Gold Top Tube Temperature:Refrigerate MSHS 70424 ALTERNATIVE PATHWAY (AH50) MSHS 70183 ALUMINUM, PLASMA/SERUM MSHS 3035 ALUMINUM, URINE Container:Urine Container Temperature:Refrigerated. Also acceptable: Room temperature or frozen MSHS 70003 AMEBIASIS ANTIBODIES MSHS 1521 AMIKACIN-TROUGH Container:Gold Top Tube Temperature:Refrigerate MSHS 70242 AMITRIPTYLINE (ELAVIL), SERUM MSHS 4430 AML MUTATION PANEL Temperature:Refrigerate MSHS 1107 AMMONIA Container:Green Top Tube Temperature:Refrigerate MSHS 60555 AMPA-R AB IF TITER ASSAY, S Container:Red Top Temperature:Refrigerate MSHS 52019 AMPHETAMINE (GC/MS), URINE MSHS 72058 AMPHETAMINE CONFIRMATION, UR MSHS 70602 AMPHETAMINE SCREEN URINE MSHS 70583 AMPHETAMINE, S/P MSHS 73237 AMPHIPHYSIN IMMUNOBLOT, S Container:Red Top Temperature:Refrigerate MSHS 60552 AMPHIPHYSIN WESTERN BLOT, S Container:Red Top Temperature:Refrigerate MSHS 1109 AMYLASE Container:Gold Top Tube Temperature:Refrigerate MSHS 1448 AMYLASE FLUID Container:Red Top Tube/Sterile Container Temperature:Refrigerate MSHS 70425 AMYLASE ISOENZYMES MSHS 1433 AMYLASE, UR - TIMED Container:Urine Container Temperature:Refrigerate MSHS 1240 AMYLASE, URINE Container:Urine Container Temperature:Refrigerate MSHS 72172 ANA W/REFLEX IF POSITIVE MSHS 3837 ANACHOICE CASCADING REFL. Container:Gold SST Ref Lab Temperature:Refrigerate MSHS 396 ANAEROBIC CULTURE Container:Sterile Container Temperature:Refrigerate Page 5 of 308 LAB CODE TEST NAME MSHS 4356 ANAPLASMA/EHRLICHIA/HISTOPLASMA BUFFY COAT Container:Lavender Top Tube Temperature:Room Temperature MSHS 72162 ANCA PANEL MSHS 4532 ANCA SCREEN W/RFLX. Container:Gold Top Tube Temperature:Refrigerate MSHS 708 ANDROSTENEDIONE MSHS 72437 ANGELMAN/PWS METHYLATION MSHS 70073 ANGIOTENSIN-CONVERT ENZYME MSHS 73238 ANNA-1 IMMUNOBLOT, S Container:Red Top Temperature:Refrigerate MSHS 73239 ANNA-2 IMMUNOBLOT, S Container:Red Top Temperature:Refrigerate MSHS 7068 ANTI A1 LECTIN Container:Pink Top Tube Temperature:Refrigerate MSHS 2731 ANTI P. SERINE Container:Gold Top Tube/Speckled Top Tube Temperature:Specimen must be transported to the laboratory within 4 hrs of draw at room temperature MSHS 7342 ANTI-A TITER IGG/IGM Container:Pink Top Tube Temperature:Refrigerate MSHS 7557 ANTI-A/ A2 SUBG.IGG/IGM Container:Pink Top Tube Temperature:Refrigerate MSHS 7343 ANTI-B TITER IGG/IGM Container:Pink Top Tube Temperature:Refrigerate MSHS 70194 ANTI-CENTROMERE B ABS MSHS 73979 Anti-cN-1A (NT5c1A) IBM (RDL) MSHS 70103 ANTI-DNA (DS) AB QN MSHS 70095 ANTI-DNASE B STREP ABS MSHS 70104 ANTI-HISTONE ABS MSHS 73980 Anti-HMGCR Ab (RDL) MSHS 21216 ANTI-HUMAN TTG-IGA Container:Gold Top Tube Temperature:Refrigerate MSHS 72536 ANTI-IGE* MSHS 70080 ANTI-JO-1 MSHS 9919 ANTI-JO-1, IGG Container:Gold SST Ref Lab Temperature:Room Temperature MSHS 70398 ANTI-MYELIN ASSOC. GLY. IGM MSHS 50505 ANTI-NEUTROPHIL CYTOPLASMIC AB, IGG Container:Gold SST Ref Lab Temperature:Refrigerate MSHS 70058 ANTI-PLA2R MSHS 72310 ANTI-SMOOTH MUSCLE/MITOCHOND. Page 6 of 308 LAB CODE TEST NAME MSHS 4330 ANTI-STREP SCREEN Container:Gold Top Tube Temperature:Refrigerate MSHS 70070 ANTI-STRIATION ABS MSHS 6510 ANTI-XA Container:Blue Top Tube Temperature:Specimen must be transported to the laboratory within 4 hrs of draw at room temperature MSHS 6521 ANTI-XA FONDAPARINUX
Load more

Recommended publications
  • The Treatment of Chyluria Secondary to Advanced Carcinoma of the Prostate
    Prostate Cancer and Prostatic Diseases (2008) 11, 102–105 & 2008 Nature Publishing Group All rights reserved 1365-7852/08 $30.00 www.nature.com/pcan CASE REPORT The treatment of chyluria secondary to advanced carcinoma of the prostate SA Cluskey, A Myatt and MA Ferro Department of Urology, Huddersfield Royal Infirmary, Huddersfield, UK Chyluria has not been previously reported as being associated with carcinoma of the prostate. The most common cause is lymphatic filariasis, a parasitic disease. Non-parasitic chyluria is rare. We describe a case of chyluria associated with carcinoma of the prostate. We describe our successful management in this case and highlight how urologists may overcome problematic chyluria in patients with advanced carcinoma of the prostate. Prostate Cancer and Prostatic Diseases (2008) 11, 102–105; doi:10.1038/sj.pcan.4500994; published online 31 July 2007 Keywords: chyluria; androgen blockade; TURP Introduction 3-week history of back pain. He had not opened his bowels for 3 days but reported passage of flatus. He Chyluria occurs as a result of abnormal communication was referred to the acute surgical team for further in- between lymphatics and the urinary tract. It may be vestigation. associated with flank pain, fever, dysuria, haematuria At the time of admission, his symptoms included and chylous clot retention.1–3 Worldwide, the most general malaise, back pain and poor mobility. He was common cause is lymphatic filariasis, a mosquito-borne indeed bed bound. He reported no difficulty in passing parasitic disease endemic to tropical and subtropical urine, although he had been treated for a suspected areas.
    [Show full text]
  • Chyluria in Pregnancy-A Decade of Experience in a Single Tertiary Care Hospital
    Nephro Urol Mon. 2015 March; 7(2): e26309. DOI: 10.5812/numonthly.26309 Research Article Published online 2015 March 1. Chyluria in Pregnancy-A Decade of Experience in a Single Tertiary Care Hospital 1 1,* 1 1 2 Khalid Mahmood ; Ahsan Ahmad ; Kaushal Kumar ; Mahendra Singh ; Sangeeta Pankaj ; 2 Kalpana Singh 1Department of Urology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India 2Department of Gynaecology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India *Corresponding author : Ahsan Ahmad, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India. Tel: +91-9431457764, E-mail: [email protected] Received: ; Revised: ; Accepted: December 29, 2014 January 4, 2015 January 22, 2015 Background: Chyluria i.e. passage of chyle in urine, giving it milky appearance, is common in many parts of India but rare in west. Very few case of chyluria in pregnant female has been reported in literature. Persistence of this condition may have deleterious effects on health of child and mother. In the present study 43 cases of chyluria during pregnancy and their management seen over a period more than 10 years have been presented. Objectives: The study aims to present our experience of managing 43 cases with chyluria during pregnancy over a period of ten years from July 2003 to June 2014. Patients and Methods: Forty three pregnant patients with chyluria, who presented between July 2003 to June 2014 to the department of Urology, Indira Gandhi Institute of Medical Sciences, Patna were included. Patients underwent conservative management and/or sclerotherapy after evaluation. Follow-up of all patients was done by observation of urine color, routine examination of urine and test for post prandial chyle in urine up to 3 months after delivery.
    [Show full text]
  • University Microfilms International 300 N
    INFORMATION TO USERS This was produced from a copy of a document sent to us for microfilming. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the material submitted. The following explanation of techniques is provided to help you understand markings or notations which may appear on this reproduction. 1. The sign or "target” for pages apparently lacking from the document photographed is "Missing Page(s)”. If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting through an image and duplicating adjacent pages to assure you of complete continuity. 2. When an image on the film is obliterated with a round black mark it is an indication that the film inspector noticed either blurred copy because of movement during exposure, or duplicate copy. Unless we meant to delete copyrighted materials that should not have been filmed, you will find a good image of the page in the adjacent frame. If copyrighted materials were deleted you will find a target note listing the pages in the adjacent frame. 3. When a map, drawing or chart, etc., is part of the material being photo­ graphed the photographer has followed a definite method in “sectioning” the material. It is customary to begin filming at the upper left hand corner of a large sheet and to continue from left to right in equal sections with small overlaps. If necessary, sectioning is continued again—beginning below the first row and continuing on until complete.
    [Show full text]
  • An Interactomics Overview of the Human and Bovine Milk Proteome Over Lactation Lina Zhang1, Aalt D
    Zhang et al. Proteome Science (2017) 15:1 DOI 10.1186/s12953-016-0110-0 RESEARCH Open Access An interactomics overview of the human and bovine milk proteome over lactation Lina Zhang1, Aalt D. J. van Dijk2,3,4 and Kasper Hettinga1* Abstract Background: Milk is the most important food for growth and development of the neonate, because of its nutrient composition and presence of many bioactive proteins. Differences between human and bovine milk in low abundant proteins have not been extensively studied. To better understand the differences between human and bovine milk, the qualitative and quantitative differences in the milk proteome as well as their changes over lactation were compared using both label-free and labelled proteomics techniques. These datasets were analysed and compared, to better understand the role of milk proteins in development of the newborn. Methods: Human and bovine milk samples were prepared by using filter-aided sample preparation (FASP) combined with dimethyl labelling and analysed by nano LC LTQ-Orbitrap XL mass spectrometry. Results: The human and bovine milk proteome show similarities with regard to the distribution over biological functions, especially the dominant presence of enzymes, transport and immune-related proteins. At a quantitative level, the human and bovine milk proteome differed not only between species but also over lactation within species. Dominant enzymes that differed between species were those assisting in nutrient digestion, with bile salt- activated lipase being abundant in human milk and pancreatic ribonuclease being abundant in bovine milk. As lactation advances, immune-related proteins decreased slower in human milk compared to bovine milk.
    [Show full text]
  • Report of the 2014 ELA Families / Scientists Meeting
    Report 2014 ELA Families - Scientists meeting April 5 & 6, 2014 Paris, France 2014 ELA FAMILIES – SCIENTISTS MEETING April 5‐6, 2014 Paris, France The 2014 ELA Families/Scientists meeting gathered 360 participants in Paris, among them 27 international scientists with expertise in leukodystrophies and myelin diseases. During the 8 diseases’ workshops and the plenary session organized, scientists presented the results of their research work in lay language and answered questions from patients and their families. This special report compiles the information presented during the scientific workshops. Summary Diseases’ workshops . Workshop on ALD/AMN . Workshop on Refsum disease . Workshop on MLD . Workshop on Krabbe disease . Workshop on CACH/VWM syndrome, Alexander disease, MLC and Canavan disease . Workshop on PMD and other hypomyelinating leukodystrophies . Workshop on undetermined leukodystrophies . Workshop on Aicardi‐Goutières syndrome ‐‐‐ *ALD: AdrenoLeukoDystrophy; AMN: AdrenoMyeloNeuropathy; MLD: Metachromatic Leukodystrophy; CACH/VWM: Childhood Ataxia with Central nervous system Hypomyelination / Vanishing White Matter; MLC: Megalencephalic Leukoencephalopathy with subcortical Cysts; PMD: Pelizaeus‐Merzbacher Disease 2014 ELA Families/Scientists meeting ‐ Report Page 1 DISEASES’ WORKSHOPS WORKSHOP ON ALD/AMN CLINICAL TRIALS EVALUATING THE IMPORTANCE OF STRENGTH ON FUNCTION IN AMN Kathleen Zackowski Ph.D., OTR, MSCS Kennedy Krieger Institute, Baltimore, MD, USA X‐linked adrenoleukodystrophy, a progressive neurodegenerative disease, is caused by a defect in the ABCD1 gene. The disease has multiple subtypes, but the most common form is adrenomyeloneuropathy (AMN). Our previous studies identified the symptoms of the disease in men as slowly progressive spasticity, weakness and sensory dysfunction. The worsening of these symptoms results in the progressive difficulty of walking and of balance problems.
    [Show full text]
  • Pediatric Multiple Sclerosis
    148 Pediatric Multiple Sclerosis Ji Y. Lee, MD, PhD1 Tanuja Chitnis, MD1 1 Department of Pediatric Neurology, Massachusetts General Hospital, Address for correspondence Tanuja Chitnis, MD, Department of Harvard Medical School, Boston, Massachusetts Pediatric Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, ACC708, Boston, MA 02114 Semin Neurol 2016;36:148–153. (e-mail: [email protected]). Abstract Pediatric multiple sclerosis (MS) is a chronic inflammatory neurologic disease that is challenging to diagnose and treat. Although there are many clinical parallels between pediatric-onset MS and adult-onset MS, there is also accumulating evidence of distin- guishing clinical features that may, in part, arise from development-specific, neuro- immune processes governing MS pathogenesis in children. Here the authors describe the clinical features, diagnosis, and treatment of pediatric MS, with a particular focus on describing clinical features and highlighting new developments that promise a better understanding of pediatric MS pathogenesis. An important task that lies ahead for pediatric neurologists is better understanding the early gene–environment interaction Keywords that precipitates the first demyelinating event in pediatric MS. This area is of particular ► multiple sclerosis importance for understanding the MS etiology and the natural history of pediatric MS. ► children Such understanding should in turn inform new developments in diagnostic tools, long- ► demyelination term therapies, and much-needed biomarkers.
    [Show full text]
  • Non-Parasitic Chyluria: a Rare Experience
    Chattogram Maa-O-Shishu Hospital Medical College Journal Volume 19, Issue 2, July 2020 Case Report Non-Parasitic Chyluria: A Rare Experience Faisal Ahmed1* Abstract Chyluria is the passage of chyle in the urine. The cause seems to be the rupture of 1 retroperitoneal lymphatics into the pyelocaliceal system, giving urine a milky Department of Paediatrics and Neonatology appearance. This condition if left untreated leads to significant morbidity because of Imperial Hospital Chattogram, Bangladesh. hematochyluria, recurrent renal colic, nutritional problems due to protein losses and immunosuppression resulting from lymphocyturia. Key words: Chyluria; Lymphatic; Pyelocaliceal system. INTRODUCTION Chyluria is the passage of chyle in the urine. The cause seems to be the rupture of retroperitoneal lymphatics into the pyelocaliceal system, giving urine a milky ap- pearance1-5. This communication is caused by the obstruction of lymphatic drainage proximal to intestinal lacteals, resulting in dilatation of distal lymphatics and the eventual rupture of lymphatic vessels into the urinary collecting system5-7. This con- dition if left untreated it leads to significant morbidity because of hematochyluria, recurrent renal colic, nutritional problems due to protein losses and immuno suppres- sion resulting from lymphocyturia. Various conservative measures like bed rest, high fluid intake, low-fat diet, fat-containing medium-chain triglycerides have been de- scribed. Chyluria may be classified as mild, moderate, or severe. Many sclerosing agents have been tried as silver nitrate, povidone iodine diluted in distillated water or pure. Povidone iodine with or without dextrose solution as a sclerosing agent was used successfully in a few studies. CASE REPORT A boy of 11 year and 6 month of age presented at OPD of Imperial Hospital, Chattogram on 9th August 2019, with the H/O passage of milky urine, mostly in the morning two years without any other complaint.
    [Show full text]
  • “Chyluria” a Rare Isolated Manifestation of Filariasis Dr
    DOI: 10.21276/sjams.2017.5.2.65 Scholars Journal of Applied Medical Sciences (SJAMS) ISSN 2320-6691 (Online) Sch. J. App. Med. Sci., 2017; 5(2E):632-634 ISSN 2347-954X (Print) ©Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com Case Report “Chyluria” A Rare Isolated Manifestation of Filariasis Dr. Tejaswini N1, Dr. Mrudul Ramachandran Nair2, Dr. Rekha N H3 1Post Graduate student, 2Post Graduate student, 3Associate Professor Department of General Medicine, Rajarajeswari Medical College and Hospital, Bangalore, Karnataka *Corresponding author Dr. Rekha N H Email: [email protected] Abstract: Chyluria is an uncommon condition characterized by passage of milky urine. Lymphatic filariasis is the most common cause of chyluria. Here we are reporting a case of chronic chyluria in an adult married female, diagnosed for filarial infection by W. bancrofti and treated medically with resolution of symptoms. Keywords: Chyluria, Filariasis, Wuchereria Bancrofti INTRODUCTION Urine routine revealed proteinuria +++ and on Chyluria is a rare clinical symptom due to microscopy there were no pus cells. Urine was negative passage of milky urine. Chyluria is a urological for AFB stain and urine culture did not show any manifestation of abnormal lymphatic system due to growth. Urinary triglyceride level was 400mg/dl and we retrograde or lateral flow of lymph from the lymphatics also observed clearance of milky white colour of urine of the kidney, ureter or bladder allowing chylous on adding equal amount of Ether and mixing vigorously material to be discharged into the urinary collecting (Figure 2). Midnight peripheral smear and DEC system.
    [Show full text]
  • A Case Report of Chyluria with Proteinuria
    2012 iMedPub Journals Vol. 3 No. 4:1 Our Site: http://www.imedpub.com/ ARCHIVES OF CLINICAL MICROBIOLOGY doi: 10.3823/255 Puranjay Saha1, Soma Sarkar1, Dipankar Sarkar2*, A Case Report Manideepa SenGupta1 of Chyluria with 1 Department of Microbiology, 2 Department of Critical-Care Correspondence: Medical College & Hospital, Medicine, Columbia-Asia Proteinuria - Filarial Kolkata, West-Bengal, India Hospital, Kolkata, [email protected] West-Bengal, India origin? An enigma * Dipankar Sarkar Department of Critical-Care Medicine, Columbia-Asia Hospital, Kolkata, West-Bengal, India Abstract Filarial infections are common in most tropical and subtropical regions of the world. We report a case of chyluria due to lymphourinary fistula in a filarial antigen negative case, the diagnosis of which was confirmed by the demonstration of microfilariae in urine as well as in peripheral blood only after diethyl carbamazine (DEC) provocation test. So In endemic areas, workup of filarial infection should be considered in a patient with chyluria even if the filarial antigen is non-reactive and microfilaria cannot be demonstrated initially. This article is available from: Keywords: Filaria, Chyluria, Filarial antigen www.acmicrob.com Introduction Filarial infections are common in most tropical and subtropical regions of the world. Numerically, the public health problem of lymphatic filariasis is greatest in India, China and Indone- sia [1]. Lymphatic filariasis is caused by Wuchereria bancrofti, Brugia malayi, or Brugia timori. The clinical manifestations are directly related to the occlusion of the lymphatic channels, thereby causing lymphangiectasia [2]. The most common pre- sentations of lymphatic filariasis are subclinical microfilaremia, acute adenolymphangitis, hydrocele ,and chronic lymphatic disease[3].
    [Show full text]
  • Canavan Disease: a Neurometabolic Disease Caused by Aspartoacylase Deficiency
    Journal of Pediatric Sciences SPECIAL ISSUE Current opinion in pediatric metabolic disease Editor: Ertan MAYATEPEK Canavan Disease: A Neurometabolic Disease Caused By Aspartoacylase Deficiency Ute Lienhard and Jörn Oliver Sass Journal of Pediatric Sciences 2011;3(1):e71 How to cite this article: Lienhard U, Sass JO. Canavan disease: a neurometabolic disease caused by aspartoacylase deficiency. Journal of Pediatric Sciences. 2011;3(1):e71 JPS 2 REVIEW ARTICLE Canavan Disease: A Neurometabolic Disease Caused By Aspartoacylase Deficiency Ute Lienhard and Jörn Oliver Sass Abstract: Canavan disease is a genetic neurodegenerative disorder caused by mutations in the ASPA gene encoding aspartoacylase, also known as aminoacylase 2. Important clinical features comprise progressive psychomotor delay, macrocephaly, muscular hypotonia as well as spasticity and visual impairment. Cerebral imaging usually reveals leukodystrophy. While it is often expected that patients with Canavan disease will die in childhood, there is increasing evidence for heterogeneity of the clinical phenotype. Aspartoacylase catalyzes the hydrolysis of N- acetylaspartate (NAA) to aspartate and acetate. Its deficiency leads to accumulation of NAA in the brain, blood, cerebrospinal fluid and in the urine of the patients. High levels of NAA in urine are detectable via the assessment of organic acids by gas chromatography - mass spectrometry. Confirmation is available by enzyme activity tests and mutation analyses. Up to now, treatment of patients with Canavan disease is only symptomatic. Although it is a panethnic disorder, information on affected individuals in populations of other than Ashkenazi Jewish origin is rather limited. Ongoing research aims at a better understanding of Canavan disease (and of related inborn errors of metabolism such as aminoacylase 1 deficiency).
    [Show full text]
  • Milk Allergen by the Numbers
    Milk allergen component testing Bos d4 Milk Bos allergen d5 Bos by the d8 numbers Detect sensitizations to the complete milk protein to create personalized management plans for your patients. High levels of milk IgE may predict the likelihood of sensitivity, but may not be solely predictive of TC 2851 reactions to baked milk or α-lactalbumin allergy duration.1 • Susceptible to heat denaturation2 • HIGHER RISK of reaction to fresh milk1,3 • LOWER RISK of reaction Milk allergen to baked milk1,3,a • Patient likely to “outgrow” component testing milk allergy4 Measurement of specific IgE by blood test that provides objective assessment of sensitization to milk is the first step in discovering your patient’s allergy. Milk allergen component tests can help α-lactalbumin β-lactoglobulin Casein Test interpretations and next steps you determine the likelihood of reaction to baked goods, such as cookies or cheese pizza, as well as • Avoid fresh milk the likelihood of allergy persistence. + + - • Likely to tolerate baked milk products • Baked milk oral food challenge (OFC), Knowing which protein your patient is with a specialist may be appropriate sensitized to can help you develop a + - - • Likely to outgrow allergy management plan.3,5-9 - + - • Avoid all forms of milk +/- +/- + • Unlikely to become tolerant of milk over time • Avoid milk and baked milk products (yogurt, cookies, cakes), as well as products processed with milk (chocolate, sausage, potato chips) % of children with milk allergy 75 do not react to baked milk.3 Bos d4 Bos Bos d5 d8 TC 2852 TC 2853 β-lactoglobulin Casein Determine • Susceptible to heat • Resistant to heat which proteins denaturation2 denaturation3 your patient is • HIGHER RISK of reaction • HIGHER RISK of reaction to fresh milk1,3 to all forms of milk1,3,5 sensitized to.
    [Show full text]
  • SNAPSHOT SNAPSHOT “Milky” Urine: a Case of Chyluria
    SNAPSHOT SNAPSHOT “Milky” urine: a case of chyluria A 53-YEAR-OLD Asian man with type 2 diabetes mellitus presented to the Emergency Department with acute onset of 1: Oral fat tolerance test generalised muscle cramps. He reported a 2-month history of polydipsia, polyuria and passing “milky” urine with blood clots. He had travelled widely throughout subtropical Asia. On examination, he was normotensive, with no lymphaden- opathy, abdominal masses or oedema. Urinalysis showed marked proteinuria, glycosuria and haematuria.The Medical The Journal urine ofprotein Australia excretion ISSN: 0025-729X rate was 19 later confirmedJanuary to 2004 be 15.57180 2 89-89 g/24 h (reference interval [RI], 0.02– 0.15 g/24©The h). Medical Urine Journal triglyceride of Australia measurement 2004 www.mja.com.au and lipopro- tein Snapshotelectrophoresis confirmed the appearance of chylo- microns in the urine after an oral fat tolerance test (Box 1). Biochemical analysis of serum showed the following levels: sodium 121mmol/L (RI, 134–146mmol/L), potassium 4.6mmol/L (RI, 3.4–5.3mmol/L), creatinine 46µmol/L (RI, Urine of patient before a 75 g oral fat tolerance test (0 h) and at 60–105µmol/L), glucose 19.7mmol/L (RI, <5.5mmol/L), fer- serial time points (0.5, 1, 2, 3, 4, and 5 h) after the test. ritin 16 mg/L (RI, 30–620mg/L), 25-hydroxyvitamin D 11nmol/L (RI, >50 nmol/L), total cholesterol 5.2mmol/L (RI, <5.5mmol/L), and triglyceride 1.8mmol/L (RI, <1.8mmol/L). 2: Contrast lymphangiography The patient had marked hypoproteinaemia and hypoalbumin- aemia, with a total protein level of 39g/L (RI, 63–80g/L) and albumin level of 21g/L (RI, 35–50g/L), respectively.
    [Show full text]